Repertoire-based mapping and time-tracking of T helper cell subsets in scRNA-Seq
This approach accurately positions the Th1, Th1-17, Th17, Th22, Th2a, Th2, T follicular helper (Tfh), and regulatory T-cell (Treg) subsets, outperforming mapping based on CITE-Seq. Remarkably, the mapping is tightly focused on specific scRNA-Seq clusters, despite 4-year interval between subset sorting and the effector CD4<sup>+</sup> scRNA-Seq experiment. These findings highlight the intrinsic program stability of Th clones circulating in peripheral blood. Repertoire overlap analysis at the scRNA-Seq level confirms that the circulating Th1, Th2, Th2a, Th17, Th22, and Treg subsets are clonally independent. However, a significant clonal overlap between the Th1 and cytotoxic CD4<sup>+</sup> T-cell clusters suggests that cytotoxic CD4<sup>+</sup> T cells differentiate from Th1 clones. In addition, this study resolves a longstanding ambiguity: we demonstrate that, while CCR10+ Th cells align with a specific Th22 scRNA-Seq cluster, CCR10-CCR6+CXCR3-CCR4+ cells, typically classified as Th17, represent a mixture of bona fide Th17 cells and clonally unrelated CCR10<sup>low</sup> Th22 cells. The clear distinction between the Th17 and Th22 subsets should influence the development of vaccine- and T-cell-based therapies. Furthermore, we show that severe acute SARS-CoV-2 infection induces systemic type 1 interferon (IFN) activation of naive Th cells. An increased proportion of effector IFN-induced Th cells is associated with a moderate course of the disease but remains low in critical COVID-19 cases. Using integrated scRNA-Seq, TCR-Track, and CITE-Seq data from 122 donors, we provide a comprehensive Th scRNA-Seq reference that should facilitate further investigation of Th subsets in fundamental and clinical studies.
Authors
- Dmitriy B. Staroverov (ORCID: https://orcid.org/0000-0001-6789-9442)
- Olga V. Britanova (ORCID: https://orcid.org/0000-0002-6295-1392)
- Daniil K. Lukyanov (ORCID: https://orcid.org/0000-0002-8037-4752)
- Konstantin А. Blagodatskikh (ORCID: https://orcid.org/0000-0002-8732-0300)
- Kristin Ladell (ORCID: https://orcid.org/0000-0002-9856-2938)
- Oleg N. Suchalko (ORCID: https://orcid.org/0000-0002-6974-2921)
- Dmitriy M. Chudakov (ORCID: https://orcid.org/0000-0003-0430-790X)
- Pavel V. Shelyakin (ORCID: https://orcid.org/0000-0003-0120-9319)
- Kelly L. Miners (ORCID: https://orcid.org/0000-0002-7046-6493)
- Irina A. Shagina (ORCID: https://orcid.org/0000-0003-3954-9108)
- André Franke (ORCID: https://orcid.org/0000-0003-1530-5811)
- Alexander Komkov (ORCID: https://orcid.org/0000-0001-9113-698X)
- Valeriia Kriukova (ORCID: https://orcid.org/0000-0002-5168-6511)
- David A. Price (ORCID: https://orcid.org/0000-0001-9416-2737)
- Bella E Minasian
- Anna S Fedosova
Institutions
- University Hospital of Wales (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Pirogov Russian National Research Medical University (RU)
- Central European Institute of Technology (AT)
- Institute of Bioorganic Chemistry (BY)
- Institut de Biologie Moléculaire et Cellulaire (FR)
- Cardiff University (GB)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-04
- DOI
- https://doi.org/10.3389/fimmu.2025.1536302
- Citations
- 3
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 2.39